Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial)

INTRODUCTION: The efficacy and safety of taspoglutide, a long-acting human glucagon-like peptide-1 analog, were compared with sitagliptin or placebo, as adjunct to metformin, in patients with inadequately controlled type 2 diabetes. METHODS: In this randomized, double-blind, double-dummy, parallel-g...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergenstal, Richard M., Forti, Adriana, Chiasson, Jean-Louis, Woloschak, Michael, Boldrin, Mark, Balena, Raffaella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508113/
https://www.ncbi.nlm.nih.gov/pubmed/23138449
http://dx.doi.org/10.1007/s13300-012-0013-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508113/
https://www.ncbi.nlm.nih.gov/pubmed/23138449
http://dx.doi.org/10.1007/s13300-012-0013-8

Ejemplares similares